Browsing by Author Liberopoulos, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 11 to 30 of 46 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Carbofuran-induced acute pancreatitisRizos, E.; Liberopoulos, E.; Kosta, P.; Efremidis, S.; Elisaf, M. S.24-Nov-2015-
Changes in serum lipids, lipoproteins and apolipoproteins in patients with acute infectionLiberopoulos, E.; Pappas, G.; Alexandridis, G.; Tsiara, S.; Milionis, H.; Bairaktari, E.; Tsianos, E.; Elisaf, M. S.24-Nov-2015-
Co-trimoxazole-induced hypouricemiaLiberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and goutLiberopoulos, E.; Christides, D.; Elisaf, M. S.24-Nov-2015-
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceMoutzouri, E.; Liberopoulos, E.; Mikhailidis, D. P.; Kostapanos, M. S.; Kei, A. A.; Milionis, H.; Elisaf, M. S.24-Nov-2015-
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaMiltiadous, G.; Bairaktari, E.; Tzallas, C.; Tsimihodimos, V.; Liberopoulos, E.; Millionis, H.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Effect of fluvastatin on plasma fibrinogen levelsLiberopoulos, E.; Tsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Rizos, E.; Katsaraki, A.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015-
The Effect of Nicotinic Acid/Laropiprant Administration on the Lipoprotein-Associated Phospholipase A2 (Lp-Pla2) Activity in Patients with Mixed DyslipidemiaKei, A.; Liberopoulos, E.; Tellis, K.; Rizos, C.; Tselepis, A.; Elisaf, M.24-Nov-2015-
The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotypeLiberopoulos, E.; Pavlidis, N.; Elisaf, M. S.24-Nov-2015-
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamideAchimastos, A.; Liberopoulos, E.; Nikas, S.; Bairaktari, E.; Miltiadous, G.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Enterococcus casseliflavus bacteremia. Case report and literature reviewPappas, G.; Liberopoulos, E.; Tsianos, E.; Elisaf, M. S.24-Nov-2015-
European Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL SubclassesMikhailidis, D. P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V. G.; de Graaf, J.; Marz, W.; Parhofer, K. G.; Rini, G. B.; Spinas, G. A.; Tomkin, G. H.; Tselepis, A. D.; Wierzbicki, A. S.; Winkler, K.; Florentin, M.; Liberopoulos, E.24-Nov-2015-
EVIDENCE OF INCREASED SDLDL PARTICLES DURING ACUTE INFECTION WITH EPSTEIN-BARR VIRUSApostolou, F.; Gazi, I.; Saougos, V.; Tselepis, A.; Elisaf, M. S.; Liberopoulos, E.24-Nov-2015-
Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic populationMiltiadous, G.; Hatzivassiliou, M.; Liberopoulos, E.; Bairaktari, E.; Tselepis, A.; Cariolou, M.; Elisaf, M.24-Nov-2015-
Hypokalaemia in alcoholic patientsElisaf, M. S.; Liberopoulos, E.; Bairaktari, E.; Siamopoulos, K.24-Nov-2015-
Hypouricaemia as a marker of a generalized proximal tubular damage in alcoholic patientsLiberopoulos, E.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015-
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidismLiberopoulos, E.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015-
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Miltiadus, G.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Milionis, H.; Bairaktari, E.; Tzallas, C.; Miltiadous, G.; Katsaraki, A.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Increase of HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activity but not of paraoxonase (PON1) during haemodialysisLiberopoulos, E.; Papavasiliou, E.; Tzallas, C.; Katopodis, K.; Gouva, C.; Christidis, D.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-